BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38154395)

  • 1. Pathogenicity assessment of a bovine viral diarrhea virus type 1l (BVDV-1l) strain in experimentally infected calves.
    Yeşilbağ K; Aytoğu G; Kadiroğlu B; Ateş Ö; Toker EB; Yaşar M
    Vet Microbiol; 2024 Feb; 289():109945. PubMed ID: 38154395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bovine viral diarrhea virus type 1a strain in China: isolation, identification, and experimental infection in calves.
    Wang W; Shi X; Tong Q; Wu Y; Xia MQ; Ji Y; Xue W; Wu H
    Virol J; 2014 Jan; 11():8. PubMed ID: 24444389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between degree of viremia and disease manifestation in calves with experimentally induced bovine viral diarrhea virus infection.
    Walz PH; Bell TG; Wells JL; Grooms DL; Kaiser L; Maes RK; Baker JC
    Am J Vet Res; 2001 Jul; 62(7):1095-103. PubMed ID: 11453486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Abdelmagid OY; Eskridge KM
    Am J Vet Res; 2005 Oct; 66(10):1785-91. PubMed ID: 16273912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bovine viral diarrhea virus transmission potential to naïve calves by direct and indirect exposure routes.
    Falkenberg SM; Dassanayake RP; Neill JD; Ridpath JF
    Vet Microbiol; 2018 Apr; 217():144-148. PubMed ID: 29615247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of three-dimensional accelerometers to evaluate behavioral changes in cattle experimentally infected with bovine viral diarrhea virus.
    Bayne JE; Walz PH; Passler T; White BJ; Theurer ME; van Santen E
    Am J Vet Res; 2016 Jun; 77(6):589-96. PubMed ID: 27227496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the onset of protection induced by a modified-live virus vaccine in calves challenge inoculated with type 1b bovine viral diarrhea virus.
    Palomares RA; Givens MD; Wright JC; Walz PH; Brock KV
    Am J Vet Res; 2012 Apr; 73(4):567-74. PubMed ID: 22452506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential exposure to bovine viral diarrhea virus and bovine coronavirus results in increased respiratory disease lesions: clinical, immunologic, pathologic, and immunohistochemical findings.
    Ridpath JF; Fulton RW; Bauermann FV; Falkenberg SM; Welch J; Confer AW
    J Vet Diagn Invest; 2020 Jul; 32(4):513-526. PubMed ID: 32484424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
    Perkins-Oines S; Dias N; Krafsur G; Abdelsalam K; Perry G; Ensley D; Jones C; Chase CCL
    Vaccine; 2023 May; 41(19):3080-3091. PubMed ID: 37045678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viremia and virus shedding in elk infected with type 1 and virulent type 2 bovine viral diarrhea virus.
    Tessaro SV; Carman PS; Deregt D
    J Wildl Dis; 1999 Oct; 35(4):671-7. PubMed ID: 10574525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute infection of calves exposed to a high-virulence or low-virulence bovine viral diarrhea virus or a HoBi-like virus.
    Ridpath JF; Falkenberg SM; Bauermann FV; VanderLey BL; Do Y; Flores EF; Rodman DM; Neill JD
    Am J Vet Res; 2013 Mar; 74(3):438-42. PubMed ID: 23438120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon lambda protects cattle against bovine viral diarrhea virus infection.
    Quintana ME; Cardoso NP; Pereyra R; Barone LJ; Barrionuevo FM; Mansilla FC; Turco CS; Capozzo AV
    Vet Immunol Immunopathol; 2020 Dec; 230():110145. PubMed ID: 33160262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation responses and virus isolation from platelets in calves experimentally infected with type I or type II bovine viral diarrhea virus.
    Walz PH; Bell TG; Grooms DL; Kaiser L; Maes RK; Baker JC
    Can J Vet Res; 2001 Oct; 65(4):241-7. PubMed ID: 11768131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a neutralising antibody response to an inoculated cytopathic strain of bovine virus diarrhoea virus.
    Westenbrink F; Straver PJ; Kimman TG; de Leeuw PW
    Vet Rec; 1989 Sep; 125(10):262-5. PubMed ID: 2552639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
    Zimmerman AD; Boots RE; Valli JL; Chase CC
    J Am Vet Med Assoc; 2006 Jun; 228(11):1757-61. PubMed ID: 16740078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.